DNA GENOTEK - Trademark Details
Status: 653 - Suspension Letter - Mailed
Serial Number
88864589
Word Mark
DNA GENOTEK
Status
653 - Suspension Letter - Mailed
Status Date
2022-01-04
Filing Date
2020-04-08
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
M70
Employee Name
BROWN, BARBARA TROFFKI
Statements
Disclaimer with Predetermined Text
"DNA"
Goods and Services
Reagents used to collect, stabilize, transport and prepare analytes (nucleic acids, proteins, metabolites) from environmental samples, swabbed from surfaces, or sourced from blood, saliva, tissue, skin, urine, feces, sputum, and other bodily fluids; Kits comprising a preserving solution and specially designed collection tube used to optimally collect, stabilize, preserve, transport and extract analytes (nucleic acids, proteins, metabolites) from environmental samples, swabbed from surfaces, or sourced from blood, saliva, tissue, skin, urine, feces, sputum and other bodily fluids extracted or collected from humans and animals all of the foregoing for scientific and research purposes
Goods and Services
Reagents used to collect, stabilize, transport and prepare analytes (nucleic acids, proteins, metabolites) from environmental samples, swabbed from surfaces, or sourced from blood, saliva, tissue, skin, urine, feces, sputum, and other bodily fluids; Kits comprising a preserving solution and specially designed collection tube used to optimally collect, stabilize, preserve, transport and extract analytes ( nucleic acids, proteins, metabolites) from environmental samples, swabbed from surfaces, or sourced from blood, saliva, tissue, skin, urine, feces, sputum and other bodily fluids extracted or collected from humans and animals all of the foregoing for clinical, medical and medical diagnostic use
Goods and Services
genetic testing for scientific and research purposes of analytes (nucleic acids, proteins, metabolites) from environmental samples, swabbed from surfaces, or sourced from blood, saliva, tissue, urine, feces, sputum, and other bodily fluids extracted or collected from humans and animals; scientific and medical research and development in the field of multi-omics, including analyte (nucleic acids, proteins, metabolites) testing, purification and extraction from blood, saliva, tissue, skin urine, feces, sputum, and other bodily fluids extracted or collected from humans and animals; laboratory services for medical, scientific, and research purposes
Goods and Services
Genetic testing for medical, clinical, and diagnostic purposes of analytes (nucleic acids, proteins, metabolites) from environmental samples, swabbed from surfaces, or sourced from blood, saliva, tissue, urine, feces, sputum, and other bodily fluids extracted or collected from humans and animals
Pseudo Mark
DEOXYRIBONUCLEIC ACID GENOTEK
Classification Information
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-08-28
Primary Code
044
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Pamela B. Huff
Address
Please log in with your Justia account to see this address.
Prior Registrations
| Relationship Type | Reel Number |
| Continuity Child | 88979001 |
Foreign Application Information
| Filing Date | Application Number | Country | Foreign Priority Claim In |
| 2020-03-25 | 2019237 | Canada | True |
| 2020-03-25 | 2019237 | Canada | True |
Trademark Events
| Event Date | Event Description |
| 2020-04-11 | NEW APPLICATION ENTERED IN TRAM |
| 2020-04-16 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2020-06-25 | ASSIGNED TO EXAMINER |
| 2020-06-30 | NON-FINAL ACTION WRITTEN |
| 2020-06-30 | NON-FINAL ACTION E-MAILED |
| 2020-06-30 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2020-08-27 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2020-08-27 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2020-08-28 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-08-31 | TEAS REQUEST TO DIVIDE RECEIVED |
| 2020-09-17 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2020-08-31 | DIVISIONAL REQUEST RECEIVED |
| 2020-09-17 | DIVISIONAL PROCESSING COMPLETE |
| 2020-09-17 | SUSPENSION LETTER WRITTEN |
| 2020-09-17 | LETTER OF SUSPENSION E-MAILED |
| 2020-09-17 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 2021-03-18 | SUSPENSION INQUIRY WRITTEN |
| 2021-03-18 | INQUIRY TO SUSPENSION E-MAILED |
| 2021-03-18 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| 2021-03-18 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| 2021-06-09 | ASSIGNED TO LIE |
| 2021-06-10 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-06-10 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-06-10 | SUSPENSION LETTER WRITTEN |
| 2021-06-10 | LETTER OF SUSPENSION E-MAILED |
| 2021-06-10 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 2021-12-10 | SUSPENSION INQUIRY WRITTEN |
| 2021-12-10 | INQUIRY TO SUSPENSION E-MAILED |
| 2021-12-10 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| 2021-12-28 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| 2022-01-04 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2022-01-04 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2022-01-04 | SUSPENSION LETTER WRITTEN |
| 2022-01-04 | LETTER OF SUSPENSION E-MAILED |
| 2022-01-04 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
